Small heat shock proteins

Carra, Serena and Alberti, Simon and Benesch, Justin L. P. and Boelens, Wilbert and Buchner, Johannes and Carver, John A. and Cecconi, Ciro and Ecroyd, Heath and Gusev, Nikolai and Hightower, Lawrence E. and Klevit, Rachel E. and Lee, Hyun O. and Liberek, Krzysztof and Lockwood, Brent and Poletti, Angelo and Timmerman, Vincent and Tóth, Erzsébet Melinda and Vierling, Elizabeth and Wu, Tangchun and Tanguay, Robert M. (2019) Small heat shock proteins. CELL STRESS & CHAPERONES, 24 (2). pp. 295-308. ISSN 1355-8145

Text CarraCellStressChap.pdf Restricted to Registered users only Download (535kB)

Abstract

Small Heat Shock Proteins (sHSPs) evolved early in the history of life; they are present in archaea, bacteria, and eukaryota. sHSPs belong to the superfamily of molecular chaperones: they are components of the cellular protein quality control machinery and are thought to act as the first line of defense against conditions that endanger the cellular proteome. In plants, sHSPs protect cells against abiotic stresses, providing innovative targets for sustainable agricultural production. In humans, sHSPs (also known as HSPBs) are associated with the development of several neurological diseases. Thus, manipulation of sHSP expression may represent an attractive therapeutic strategy for disease treatment. Experimental evidence demonstrates that enhancing the chaperone function of sHSPs protects against age-related protein conformation diseases, which are characterized by protein aggregation. Moreover, sHSPs can promote longevity and healthy aging in vivo. In addition, sHSPs have been implicated in the prognosis of several types of cancer. Here, sHSP upregulation, by enhancing cellular health, could promote cancer development; on the other hand, their downregulation, by sensitizing cells to external stressors and chemotherapeutics, may have beneficial outcomes. The complexity and diversity of sHSP function and properties and the need to identify their specific clients, as well as their implication in human disease, have been discussed by many of the world's experts in the sHSP field during a dedicated workshop in Québec City, Canada, on 26-29 August 2018.

Actions (login required)

Edit Item